Skip to content
  1. free shipping on all usa orders over $50
AlphaSize alpha-gpc benefits

The Mind And Muscle Benefits Of Alpha-GPC

 

Let’s talk about something that’s as important as building muscle or nailing your intervals: your brain. You’ve probably spent countless hours hammering out miles on the pavement, grinding up hills on the bike, and hitting the gym to build that strength base. But there’s a training tool you might be overlooking, and it’s sitting between your ears. Your mind could be the difference between hitting a PR or falling flat when it counts.

Pushing through pain, staying laser-focused, and connecting your brain to your muscles—that’s where the magic happens. Research backs this up (check out Endure by Alex Hutchinson if you want a deep dive), showing how training your brain can boost performance just as much as any physical workout.

But there’s one supplement that can help take your focus and mind-muscle connection to the next level: Alpha-GPC. This powerhouse nootropic not only sharpens your mental game but also enhances muscle contractions. Let’s break it down.

Fast Facts on Alpha-GPC

  • Alpha-GPC is the most bioavailable form of choline, a nutrient that fuels your brain and muscles.
  • It can boost endurance performance by increasing choline levels, improving muscle contractions, and keeping your brain sharp.
  • Take 300-1200 mg about 30 minutes before exercise for best results.
  • Research shows Alpha-GPC is effective and safe for athletes.

What Does Alpha-GPC Stand For?

Alpha-GPC stands for Alpha-glycerophosphocholine—yeah, it’s a mouthful, but what it does is simple: it enhances both your mental and physical performance.

What Does Alpha-GPC Do?

Alpha-GPC is a cholinergic compound derived from soy lecithin, making it the best source of choline for your body. When you take Alpha-GPC, it gets converted into choline, which helps your brain send signals to your muscles. That’s where the real magic happens: acetylcholine—the neurotransmitter responsible for muscle contractions and cognitive sharpness—gets a boost.

Here’s the quick science: acetylcholine is crucial for controlling muscle contractions and keeping your mind sharp during long, grueling efforts. When you run low on choline, those muscle contractions start to suck, and you lose that mental edge. Alpha-GPC replenishes your body’s choline pool, giving you stronger contractions and a clearer head when the going gets tough.

Alpha-GPC Benefits

Let’s hit the highlights of what Alpha-GPC can do for you as an endurance athlete:

  1. Energy and Endurance: Choline regulates metabolism, helping your body store fat or tap it as fuel for your muscles.
  2. Mind-Muscle Connection: By supporting communication between your brain and muscles, Alpha-GPC ensures more precise and efficient movements, which can boost performance and cognition.
  3. Fight Fatigue: Alpha-GPC delays mental and physical fatigue by keeping your nervous system firing on all cylinders.
  4. Boost Oxygen Delivery: It helps protect nitric oxide levels, which increase blood flow to your working muscles, delivering more oxygen and nutrients when you need them most.

Alpha-GPC Dosage

The sweet spot for most athletes is between 300-600 mg before exercise, which is enough to boost power output, cognition, and even growth hormone secretion. If you want to go all-in on mental focus and mind-muscle connection, you can crank it up to 1200 mg.

Take it about 30 minutes before your workout to get those plasma choline levels elevated and ready to roll. You’ll stay in the zone for around two hours, and after 24 hours, everything returns to baseline.

Research on Alpha-GPC and Endurance Athletes

Let’s talk numbers. Research shows that choline supplementation, especially through Alpha-GPC, can be a game-changer for endurance athletes. Here’s the scoop:

  • In long-distance runners, choline supplementation increased plasma choline levels by 18% during exercise and 54% after. And when choline was supplemented, these runners recovered 12% faster with lower lactic acid levels.

  • In cyclists and triathletes, choline helped maintain plasma levels even after a grueling two-hour ride at an average of 35 km/h. Without supplementation, plasma choline dropped by 17%, and lactic acid levels shot up. With choline? Lactic acid decreased by up to 25% after two hours.

Bottom line: choline, especially Alpha-GPC, keeps you in the fight longer and helps you recover faster, whether you’re pounding out miles or cranking up the watts on the bike.

Are There Any Side Effects?

Good news—Alpha-GPC has been shown to have zero negative effects on heart rate, blood pressure, or any major health markers. Some people might experience mild headaches if they take higher doses (1000 mg or more), but starting at 300 mg usually helps avoid that.

The Bottom Line on Alpha-GPC

Alpha-GPC is a no-brainer (pun intended) if you want to level up both your mental and physical game. It’s safe, effective, and backed by research, making it a great addition to your endurance arsenal. Stronger muscle contractions, sharper focus, and faster recovery—what more could you ask for?

So, if you’re looking to connect the dots between your brain and your muscles, give Alpha-GPC a shot. It might just be the secret weapon you’ve been missing.

 

References:

1. Sigala S., Imperato A., Rizzonelli P., Casolini P., Missale C., Spano P. L-α-glycerylphorylcholine antagonizes scopolamine-induced amnesia and enhances hippocampal cholinergic transmission in the rat. Eur. J. Pharmacol. 1992;211:351–358. doi: 10.1016/0014-2999(92)90392-H. [PubMed] [CrossRef] []
2. Amenta F., Tayebati S.K., Vitali D., Di Tullio M.A. Association with the cholinergic precursor choline alphoscerate and the cholinesterase inhibitor rivastigmine: An approach for enhancing cholinergic neurotransmission. Mech. Ageing Dev. 2006;127:173–179. doi: 10.1016/j.mad.2005.09.017. [PubMed] [CrossRef] []
3. Tomassoni D., Avola R., Mignini F., Parnetti L., Amenta F. Effect of treatment with choline alphoscerate on hippocampus microanatomy and glial reaction in spontaneously hypertensive rats. Brain Res. 2006;1120:183–190. doi: 10.1016/j.brainres.2006.08.068. [PubMed] [CrossRef] []
4. Lee S.H., Choi B.Y., Kim J.H., Kho A., Sohn M., Song H.K., Choi H.C., Suh S.W. Late treatment with choline alfoscerate (l-alpha glycerylphosphorylcholine, α-GPC) increases hippocampal neurogenesis and provides protection against seizure-induced neuronal death and cognitive impairment. Brain Res. 2017;1654:66–76. doi: 10.1016/j.brainres.2016.10.011. [PubMed] [CrossRef] []
5. Parnetti L., Abate G., Bartorelli L., Cucinotta D., Cuzzupoli M., Maggioni M., Villardita C., Senin U. Multicentre Study of l-??-Glyceryl-Phosphorylcholine vs ST200 among Patients with Probable Senile Dementia of Alzheimer??s Type. Drugs Aging. 1993;3:159–164. doi: 10.2165/00002512-199303020-00006. [PubMed] [CrossRef] []
6. Moreno M.D.J.M. Cognitive improvement in mild to moderate Alzheimer’s dementia after treatment with the acetylcholine precursor choline alfoscerate: A multicenter, double-blind, randomized, placebo-controlled trial. Clin. Ther. 2003;25:178–193. doi: 10.1016/S0149-2918(03)90023-3. [PubMed] [CrossRef] []
7. Sangiorgi G.B., Barbagallo M., Giordano M., Meli M., Panzarasa R. α-Glycerophosphocholine in the Mental Recovery of Cerebral Ischemic Attacks. Ann. N. Y. Acad. Sci. 1994;717:253–269. doi: 10.1111/j.1749-6632.1994.tb12095.x. [PubMed] [CrossRef] []
8. Parnetti L., Amenta F., Gallai V. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: An analysis of published clinical data. Mech. Ageing Dev. 2001;122:2041–2055. doi: 10.1016/S0047-6374(01)00312-8. [PubMed] [CrossRef] []
9. Parnetti L., Mignini F., Tomassoni D., Traini E., Amenta F. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: Ineffective approaches or need for re-evaluation? J. Neurol. Sci. 2007;257:264–269. doi: 10.1016/j.jns.2007.01.043. [PubMed] [CrossRef] []
10. Tayebati S.K., Tomassoni D., Nwankwo I.E., Di Stefano A., Sozio P., Cerasa L.S., Amenta F. Modulation of monoaminergic transporters by choline-containing phospholipids in rat brain. CNS Neurol. Disord.-Drug Targets. 2013;12:94–103. doi: 10.2174/1871527311312010015. [PubMed] [CrossRef] []
11. Björklund A., Dunnett S.B. Dopamine neuron systems in the brain: An update. Trends Neurosci. 2007;30:194–202. doi: 10.1016/j.tins.2007.03.006. [PubMed] [CrossRef] []
12. Salamone J.D., Cousins M.S., Bucher S. Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in a T-maze cost/benefit procedure. Behav. Brain Res. 1994;65:221–229. doi: 10.1016/0166-4328(94)90108-2. [PubMed] [CrossRef] []
13. Robinson S., Sandstrom S.M., Denenberg V.H., Palmiter R.D. Distinguishing Whether Dopamine Regulates Liking, Wanting, and/or Learning About Rewards. Behav. Neurosci. 2005;119:5–15. doi: 10.1037/0735-7044.119.1.5. [PubMed] [CrossRef] []
14. Bromberg-Martin E.S., Matsumoto M., Hikosaka O. Dopamine in Motivational Control: Rewarding, Aversive, and Alerting. Neuron. 2010;68:815–834. doi: 10.1016/j.neuron.2010.11.022. [PMC free article] [PubMed] [CrossRef] []
15. Aberman J., Ward S., Salamone J. Effects of Dopamine Antagonists and Accumbens Dopamine Depletions on Time-Constrained Progressive-Ratio Performance. Pharmacol. Biochem. Behav. 1998;61:341–348. doi: 10.1016/S0091-3057(98)00112-9. [PubMed] [CrossRef] []
16. Trifilieff P., Feng B., Urizar E., Winiger V., Ward R.D., Taylor K.M., Martinez D., Moore H., Balsam P.D., Simpson E., et al. Increasing dopamine D2 receptor expression in the adult nucleus accumbens enhances motivation. Mol. Psychiatry. 2013;18:1025–1033. doi: 10.1038/mp.2013.57. [PMC free article] [PubMed] [CrossRef] []
17. Jacobs B.L., Azmitia E. Structure and function of the brain serotonin system. Physiol. Rev. 1992;72:165–229. doi: 10.1152/physrev.1992.72.1.165. [PubMed] [CrossRef] []
18. Sharp T., Barnes N.M. Central 5-HT receptors and their function; present and future. Neuropharmacology. 2020;177:108155. doi: 10.1016/j.neuropharm.2020.108155. [PubMed] [CrossRef] []
19. Richardson-Jones J.W., Craige C.P., Nguyen T.H., Kung H.F., Gardier A.M., Dranovsky A., David D.J., Guiard B.P., Beck S.G., Hen R., et al. Serotonin-1A Autoreceptors Are Necessary and Sufficient for the Normal Formation of Circuits Underlying Innate Anxiety. J. Neurosci. 2011;31:6008–6018. doi: 10.1523/JNEUROSCI.5836-10.2011. [PMC free article] [PubMed] [CrossRef] []
20. Kume S., Nishimura Y., Mizuno K., Sakimoto N., Hori H., Tamura Y., Yamato M., Mitsuhashi R., Akiba K., Koizumi J.-I., et al. Music Improves Subjective Feelings Leading to Cardiac Autonomic Nervous Modulation: A Pilot Study. Front. Neurosci. 2017;11:108. doi: 10.3389/fnins.2017.00108. [PMC free article] [PubMed] [CrossRef] []
21. Brownawell A.M., Carmines E.L., Montesano F. Safety assessment of AGPC as a food ingredient. Food Chem. Toxicol. 2011;49:1303–1315. doi: 10.1016/j.fct.2011.03.012. [PubMed] [CrossRef] []